Clinical Trials Browser

Phase 2/3 × Locally Advanced Resectable Rectal Cancer × 90 days × Clear all

NCT07454720 2026-05-05

A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Phase 2/3 Recruiting

Gastrointestinal

Locally Advanced Resectable Rectal Cancer